Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 8
Treatment-assignment count: 0
Stratification count: 0
pancreatic cancer · Therapy Not Normalized
RET fusion is flagged as manual review required because public trials show inclusion required evidence in 11 contexts. FDA CDx context should be reviewed manually.
Strongest role: Inclusion Required
Inclusion-required count: 8
Treatment-assignment count: 0
Stratification count: 0
Threshold count: 0
Common snippets: None extracted
Threshold label: Low
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Low
Signal count: 0
Recent signals: 0
Density label: Low
https://clinicaltrials.gov/study/NCT06387342 | https://clinicaltrials.gov/study/NCT02166255 | https://clinicaltrials.gov/study/NCT02427841 | https://clinicaltrials.gov/study/NCT07319416 | https://clinicaltrials.gov/study/NCT07649928 | https://clinicaltrials.gov/study/NCT04493060 | https://clinicaltrials.gov/study/NCT06958328 | https://clinicaltrials.gov/study/NCT07024615 | https://clinicaltrials.gov/study/NCT07627711 | https://clinicaltrials.gov/study/NCT07480928 | https://clinicaltrials.gov/study/NCT07039526